Device_and_Drug_Products_Workshop_Right

  • Written by ajiang
  • June 13, 2010 at 11:32 pm
  • Gershon Capital provides advisory services to healthcare and life science companies through its relationship with Gershon & Company, our consulting arm founded in 1999. The Gershon & Company advisory group leverages its senior management team and industry networks to bring sector expertise, investment experience, and regulatory, scientific and medical knowledge to emerging healthcare and life science companies, hedge funds, private equity firms, and government.

    Through a multidisciplinary team of industry, regulatory, and scientific specialists, Gershon Capital helps organizations to prevent and resolve compliance problems and to develop efficient and effective strategies for the submission and approval of drugs, biologics, and devices. The company deploys only highly experienced consultants who consistently deliver top-quality results for a diverse base of global clients—including pharmaceutical biologic, biotechnology, medical device, and dietary supplement companies and the law firms that serve them.

    For additional information, contact:

    Roy Sturgeon, Ph.D., Roy J. Sturgeon, President, Lachman Consultants & Affiliate Advisor, Gershon Capital & Cie

    Email: rsturgeon@gershoncapital.com

  • Conference Info:

     

    Date: June 26-27, 2013
    Location: The Metropolitan Club, New York City


    Audience: Institutional investors, high net worth individual investors, family offices, business development executives throughout the US and Europe building and financing high growth medical technology, health care and life science companies.

    View the Schedule!

    View the Agenda!